Genetics and Functional Genomics of Multiple Sclerosis: From Risk Loci to Disease Mechanisms
Kim and Patsopoulos’ review, “Genetics and functional genomics of multiple sclerosis,” examines how modern genetic research has reshaped the understanding of multiple sclerosis (MS), an inflammatory and neurodegenerative disease of the central nervous system. The article emphasizes that MS is not caused by a single genetic defect, but by a complex interaction between genetic predisposition and environmental exposures such as vitamin D status, smoking, and Epstein–Barr virus infection. The overview diagram on page 2 frames the review around four major themes: evidence for genetic predisposition, common variants identified through genome-wide association studies, rare and low-frequency variants, and functional characterization of genetic loci.
Genetic Predisposition and the Role of HLA
A central argument of the article is that MS has a substantial heritable component. Twin and family studies show that monozygotic twins have a much higher concordance rate than dizygotic twins, and first-degree relatives of affected individuals carry an increased risk. The earliest and strongest genetic association lies within the human leukocyte antigen region, particularly HLA-DRB1*15:01, located in the major histocompatibility complex on chromosome 6. This finding is biologically coherent because HLA molecules regulate antigen presentation and immune recognition, processes that are highly relevant to autoimmune disease.
Genome-Wide Association Studies and MS Susceptibility
The review describes genome-wide association studies as a decisive turning point in MS genetics. Earlier candidate-gene and linkage studies had limited success, largely because of small sample sizes and restricted variant testing. In contrast, GWAS enabled systematic interrogation of hundreds of thousands of variants across large cohorts. The first major MS GWAS identified non-HLA associations in IL2RA and IL7RA, genes with direct immunological relevance. Later studies expanded the list of robust susceptibility loci to more than 200, demonstrating that MS risk is polygenic and strongly enriched in immune regulatory pathways.
Beyond Common Variants: Rare Variants and Disease Phenotypes
The article also addresses the limitations of GWAS, particularly its reduced power to detect rare and low-frequency variants. Exome-array and sequencing approaches have begun to explore whether coding variation contributes to MS susceptibility. Variants in genes such as HDAC7 and NLRP8 are discussed as examples of low-frequency associations, although their contribution to overall heritability appears modest. The authors further examine genetic studies of MS-related phenotypes, including disease severity, age at onset, MRI-derived traits, oligoclonal bands, immunoglobulin G index, and relapse rate. These studies suggest that genetic determinants of susceptibility may not fully overlap with genetic determinants of progression.
Genetic Architecture Across Populations and Autoimmune Diseases
A notable strength of the review is its discussion of ancestry and shared autoimmunity. Most large MS genetic studies have been conducted in individuals of European ancestry, but emerging evidence indicates that MS also affects non-European populations and may be underrecognized in some groups. Studies in African American, Hispanic, Kuwaiti, Chinese, and Japanese cohorts suggest both shared and ancestry-specific genetic effects. The chart on page 7 further illustrates genetic correlations between MS and other autoimmune diseases, including systemic lupus erythematosus, inflammatory bowel disease, type 1 diabetes, rheumatoid arthritis, and primary biliary cirrhosis. This reinforces the concept that MS belongs to a broader network of immune-mediated disorders.
Functional Genomics and Biological Interpretation
The most important challenge after GWAS is translating statistical associations into biological mechanisms. Many MS-associated variants lie in non-coding regions, implying regulatory functions rather than direct protein alteration. The review highlights functional studies of loci such as TNFRSF1A, EVI5, ATXN1, NFKB1, and MERTK. For example, the regional association plot on page 9 shows the TNFRSF1A locus, where the risk variant rs1800693 is linked to altered splicing and production of a soluble TNF receptor form. This finding is especially important because anti-TNF therapies have worsened MS activity in clinical contexts, showing how genetic mechanisms can illuminate therapeutic risk.
Future Directions in MS Genomics
The article concludes that MS genetics has entered a functional era. While more than 200 susceptibility loci have been identified, the causal genes, cell types, and molecular pathways remain incompletely resolved. The authors highlight single-cell technologies as a major future direction, particularly for dissecting immune-cell subsets, microglia, astrocytes, oligodendrocytes, and neurons in MS pathogenesis. Future research will need larger sequencing cohorts, better representation of diverse ancestries, sex-stratified genetic analyses, and deeper integration of GWAS with transcriptomic, epigenomic, proteomic, and single-cell datasets. Overall, the review presents MS as a genetically complex immune-mediated neurological disease whose molecular architecture is increasingly accessible but still far from fully explained.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Kim, W., Patsopoulos, N. Genetics and functional genomics of multiple sclerosis. Semin Immunopathol 44, 63–79 (2022). https://doi.org/10.1007/s00281-021-00907-3
